| Report ID | 270965 |
| Drug Identification Number | 02522373 |
| Brand name | DORZOLAMIDE |
| Common or Proper name | Dorzolamide Hydrochloride Ophthalmic Solution |
| Company Name | JAMP PHARMA CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | DORZOLAMIDE |
| Strength(s) | 20MG |
| Dosage form(s) | SOLUTION |
| Route of administration | OPHTHALMIC |
| Packaging size | 5 mL |
| Anatomical Therapeutical Chemical (ATC) code | S01EC |
| Anatomical Therapeutical Chemical (ATC) description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2025-10-31 |
| Estimated end date | 2026-04-24 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2026-02-20 |
| Company comments | Allocation |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2026-02-20 | French | Compare |
| v5 | 2026-02-20 | English | Compare |
| v4 | 2026-01-27 | French | Compare |
| v3 | 2026-01-27 | English | Compare |
| v2 | 2025-11-03 | French | Compare |
| v1 | 2025-11-03 | English | Compare |
Showing 1 to 6 of 6